Skip to main content

Actors and Networks database

The evolving field of gene and cell therapy is supported by a large community of academic, clinical, translational, regulatory and patient organisations. The Actors and Networks database maps these stakeholders in Europe and beyond, their activities, and resources they have produced. 

EuroGCT has developed and compiled this database for those interested in identifying the actors involved at each stage of the pathways bringing gene and cell therapies from lab to clinic. Coming from an academic perspective, our focus is to map information that has not been mapped elsewhere. This includes documenting the various types of interconnected regulators, patient groups actively involved along the pathways, and non-profit organisations devoted to therapy development. In its first iteration, this database does not yet include commercial partners and service providers.

Additional complementary work by other organisations on GCT stakeholders mapping can be found here.

A scientific paper on actors has also been published in Humanities and Social Sciences Communications. You can find its lay summary here.

Showing 10 of 373

French Regional Health Agencies (Agences régionales de santé) (ARS)

Region/Country:  
  • Countries in the EU/EEA
  • France

Type of Actor:

  • Research Funding Authorities
  • National Research Funding Authorities

Development Stage:

  • Fundamental Research
  • Translational Research
  • Clinical Research

Additional information

The Regional Health Agencies (ARS) are piloting public health policy on the local level in the deconcentrated regions. The regional health agencies contribute to the dissemination of innovations at regional level, in conjunction with their regional partners and the local innovation players closest to patients. Responsible for regulating and financing the regional healthcare system, they finance, coordinate and implement innovation in healthcare.

Genopole

Region/Country:  
  • Countries in the EU/EEA
  • France

Type of Actor:

  • Patient Organisations
  • Regional/Local Patient Organisations

German Central Authority of the Länder for Health Protection with regard to Medicinal Products and Medical Devices (Zentralstelle der Länder für Gesundheitsschutz bei Arzneimitteln und Medizinprodukten) (ZLG)

Region/Country:  
  • Countries in the EU/EEA
  • Germany

Type of Actor:

  • Regulators
  • Medical Devices Entities
  • Medical Device Authorities
  • National Medical Device Authorities

Development Stage:

  • Manufacturing
  • Commercialisation

German Federal Commissioner for Data Protection and Freedom of Information (Bundesbeauftragte für den Datenschutz und die Informationsfreiheit) (BfDI)

Region/Country:  
  • Countries in the EU/EEA
  • Germany

Type of Actor:

  • Regulators
  • Data Authorities
  • National Data Authorities

Development Stage:

  • Fundamental Research
  • Clinical Research
  • Translational Research
  • Health Data

German Federal Institute for Drugs and Medical Devices (Bundesinstitut für Arzneimittel und Medizinprodukte) (BfArM)

Region/Country:  
  • Countries in the EU/EEA
  • Germany

Type of Actor:

  • Regulators
  • Medicines Agencies
  • National Medicines Agencies
  • Medical Devices Entities
  • Medical Device Authorities
  • National Medical Device Authorities

Development Stage:

  • Fundamental Research
  • Clinical Research
  • Manufacturing
  • Commercialisation

German Federal Ministry of Health (Bundesministerium für Gesundheit) (BMG)

Region/Country:  
  • Countries in the EU/EEA
  • Germany

Type of Actor:

  • Regulators
  • Other National competent authorities
  • Competent Authorities for Tissues and Cells
  • Competent Authorities for Blood and Blood Components

Development Stage:

  • Fundamental Research
  • Translational Research
  • Clinical Research
  • Manufacturing
  • Commercialisation

German Federal Office of Consumer Protection and Food Safety (Bundesamt für Verbraucherschutz und Lebensmittelsicherheit) (BVL)

Region/Country:  
  • Countries in the EU/EEA
  • Germany

Type of Actor:

  • Regulators
  • Other National competent authorities
  • Competent Authorities for GMO

Development Stage:

  • Fundamental Research
  • Clinical Research
  • Manufacturing
  • Commercialisation

German Patent and Trademark Office (Deutsches Patent- und Markenamt) (DPMA)

Region/Country:  
  • Countries in the EU/EEA
  • Germany

Type of Actor:

  • Regulators
  • Patent Offices
  • National Patent Offices

Development Stage:

  • Fundamental Research

German Stem Cell Network (GSCN)

Region/Country:  
  • Countries in the EU/EEA
  • Germany

Type of Actor:

  • Networks
  • Non-profit Research Organisations
  • Training Providers
  • National and International Societies
  • European and Regional Networks

Development Stage:

  • Fundamental Research
  • Clinical Research
  • Translational Research
  • Manufacturing
  • Commercialisation
  • Patient and Public Involvement

Additional information

The German Stem Cell Network (GSCN) aims at creating synergies between all areas of basic and applied stem cell research and to provide an interface between science, education, politics and society as a whole. The central task of the GSCN is to pool the expertise in stem cell research in Germany and develop synergies between basic research, regenerative medicine and pharmacology. The initiative promotes innovative research activities on a national and international level. In addition, targeted information and events are offered to encourage the public discourse on stem cell research. Since 1 January 2021 the GSCN works in a tight cooperation with the Berlin Institute of Health (BIH). The GSCN and the BIH have formed a "Dialog Platform Stem Cell Research" as a project to foster stem cell research as basic science and in the translation.

Germany Federal Joint Committee (Gemeinsamer Bundesausschuss) (G-BA)

Region/Country:  
  • Countries in the EU/EEA
  • Germany

Type of Actor:

  • Regulators
  • HTA Bodies

Development Stage:

  • Commercialisation
Did you find the content on this page useful? If not, you can leave us a message so we can improve Send us your thoughts